Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharma Industry / Biotech Industry News

Cambridge Consultants To Unveil New Licensing Program For Dry Powder Inhaler "Gen-X" Development Tools At The Respiratory Drug Delivery Conference

Main Category: Pharma Industry / Biotech Industry
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 13 May 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Accelerating the creation of new inhalable drug delivery devices, Cambridge Consultants (http://www.cambridgeconsultants.com) is announcing the licensing of a range of technology development tools at the Respiratory Drug Delivery Conference in Scottsdale, Ariz. The company's Gen-X series of technologies, from de-agglomeration for fine particle doses (FPD) to drug storage chamber piercing and evacuation techniques, draw on the scientific and engineering expertise of being involved in the development of more than 16 respiratory delivery devices over the past 15 years.

"In an industry where the time-to-market for inhalable dry powder drug delivery devices is often seven to 10 years, fast-tracking development with our proven Gen-X development platform can significantly reduce this timescale and the overall development risk." said Marek Myszko, business development manager, Drug Delivery at Cambridge Consultants. "A 40- to 60-percent reduction in time to market creates a significant competitive value and faster revenue to a company's bottom line in a market where generating market presence is particularly important."

The group of core Gen-X technologies being licensed by Cambridge Consultants include the technology to accurately pierce a foil blister, evacuate the blister in a repeatable manner, and drug de-agglomerate technologies to provide tailored device performance. These, coupled with Cambridge Consultants' proven expertise in the development of solutions to technical challenges such as dose indexing and human factors, provide a quick development path for new DPIs.

Cambridge Consultants is highlighting its Gen-X DPI technologies at the Respiratory Drug Delivery 2008 conference in Scottsdale, Ariz., from May 11-15.

About Cambridge Consultants

Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology critical issues for clients worldwide. For nearly 50 years, the company has enabled its clients to turn business opportunities into commercial successes, whether launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of over 250 engineers, designers, scientists and consultants, in offices in Cambridge (UK) and Boston (USA), Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, automotive, transport, energy and wireless communications. For more information visit: http://www.cambridgeconsultants.com.

Cambridge Consultants is part of the Altran group of companies. Altran Technologie, which is listed on the Paris Stock Exchange (FR:003463), employs more than 17,000 consultants in 20 countries around the world. In 2006 the group generated a turnover of €1,495.6 million.

http://www.altran.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
24 Jun 2009
Patients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets. This new medication for the relief of moderate to severe...


Finding Relief for Your Aching Back
Finding Relief for Your Aching Back

Ed is taking the conservative approach to treating his lower back pain. His physiatrist, Dr. Neal Mesnick, says strengthening the core muscles that support the spine is the key to success. He also says surgery should only be a last resort.

more videos are available in our health videos section.